{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:21:16Z","timestamp":1794320476958,"version":"4.9.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01 AG072177"],"award-info":[{"award-number":["U01 AG072177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30AG072972"],"award-info":[{"award-number":["P30AG072972"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 LM012535"],"award-info":[{"award-number":["R01 LM012535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U19AG074879"],"award-info":[{"award-number":["U19AG074879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000199","name":"United States Department of Agriculture","doi-asserted-by":"crossref","award":["Project 2032-51530-025-00D"],"award-info":[{"award-number":["Project 2032-51530-025-00D"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia","award":["2009965"],"award-info":[{"award-number":["2009965"]}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["NIA R01AG046171"],"award-info":[{"award-number":["NIA R01AG046171"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["RF1AG051550"],"award-info":[{"award-number":["RF1AG051550"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["RF1AG057452"],"award-info":[{"award-number":["RF1AG057452"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01AG059093"],"award-info":[{"award-number":["R01AG059093"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["RF1AG058942"],"award-info":[{"award-number":["RF1AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["U01AG061359"],"award-info":[{"award-number":["U01AG061359"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["U19AG063744"],"award-info":[{"award-number":["U19AG063744"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["3U19AG063744-04S1"],"award-info":[{"award-number":["3U19AG063744-04S1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["1R01AG081322"],"award-info":[{"award-number":["1R01AG081322"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["FNIH: #DAOU16AMPA"],"award-info":[{"award-number":["FNIH: #DAOU16AMPA"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation is an important factor in Alzheimer\u2019s disease (AD). An NMR measurement in plasma, glycoprotein acetyls (GlycA), captures the overall level of protein production and glycosylation implicated in systemic inflammation. With its additional advantage of reducing biological variability, GlycA might be useful in monitoring the relationship between peripheral inflammation and brain changes relevant to AD. However, the associations between GlycA and these brain changes have not been fully evaluated. Here, we performed Spearman\u2019s correlation analyses to evaluate these associations cross-sectionally and determined whether GlycA can inform AD-relevant longitudinal measurements among participants in the Alzheimer\u2019s Disease Neuroimaging Initiative (n\u2009=\u20091506), with additional linear models and stratification analyses to evaluate the influences of sex or diagnosis status and confirm findings from Spearman\u2019s correlation analyses. We found that GlycA was elevated in AD patients compared to cognitively normal participants. GlycA correlated negatively with multiple concurrent regional brain volumes in females diagnosed with late mild cognitive impairment (LMCI) or AD. Baseline GlycA level was associated with executive function decline at 3\u20139\u00a0year follow-up in participants diagnosed with LMCI at baseline, with similar but not identical trends observed in the future decline of memory and entorhinal cortex volume. Results here indicated that GlycA is an inflammatory biomarker relevant to AD pathogenesis and that the stage of LMCI might be relevant to inflammation-related intervention.<\/jats:p>","DOI":"10.1038\/s41598-024-67177-5","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T10:12:46Z","timestamp":1722247966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Nuanyi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Borkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Metabolomics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kueider-Paisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Mahmoudiandehkhordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Welsh-Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Plassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Risacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Dorrestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeran","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Labus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Fiehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Barupal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Mazmanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"van Duijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najaf","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejo","family":"Nevado-Holgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranga","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Keshavarzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arfan","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Baloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Farrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"W\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Koal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Krumsiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Suhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatania","family":"Foroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"67177_CR1","doi-asserted-by":"crossref","unstructured":"Kinney, J.W., Bemiller, S.M., Murtishaw, A.S., Leisgang, A.M., Salazar, A.M., Lamb, B.T. Inflammation as a central mechanism in Alzheimer\u2019s disease. 2018 (2352\u20138737 (Electronic)).","DOI":"10.1016\/j.trci.2018.06.014"},{"issue":"5","key":"67177_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A. & Bennett, D. A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 61(5), 661\u2013666 (2004).","journal-title":"Arch Neurol."},{"issue":"1","key":"67177_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2012.07.032","volume":"322","author":"RN Kalaria","year":"2012","unstructured":"Kalaria, R. N., Akinyemi, R. & Ihara, M. Does vascular pathology contribute to Alzheimer changes?. J. Neurol. Sci. 322(1), 141\u2013147 (2012).","journal-title":"J. Neurol. Sci."},{"issue":"9046","key":"67177_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","volume":"349","author":"A Hofman","year":"1997","unstructured":"Hofman, A. et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study. Lancet. 349(9046), 151\u2013154 (1997).","journal-title":"Lancet."},{"issue":"9009","key":"67177_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","volume":"347","author":"I Skoog","year":"1996","unstructured":"Skoog, I. et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 347(9009), 1141\u20131145 (1996).","journal-title":"Lancet."},{"issue":"1","key":"67177_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneur.64.1.93","volume":"64","author":"G Razay","year":"2007","unstructured":"Razay, G., Vreugdenhil, A. & Wilcock, G. The metabolic syndrome and Alzheimer Disease. Arch. Neurol. 64(1), 93\u201396 (2007).","journal-title":"Arch. Neurol."},{"issue":"2","key":"67177_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron, F., Krauthausen, M., Kummer, M. & Heneka, M. T. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: A comparative overview. Mol. Neurobiol. 50(2), 534\u2013544 (2014).","journal-title":"Mol. Neurobiol."},{"key":"67177_CR8","unstructured":"Swardfager W, Lanct\u00f4t K Fau-Rothenburg L, Rothenburg L Fau-Wong A, Wong A Fau-Cappell J, Cappell J Fau-Herrmann N, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. (1873\u20132402 (Electronic))."},{"issue":"1","key":"67177_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","volume":"13","author":"K Borkowski","year":"2021","unstructured":"Borkowski, K. et al. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease. Alzheimer\u2019s Res. Therapy. 13(1), 149 (2021).","journal-title":"Alzheimer\u2019s Res. Therapy."},{"issue":"1","key":"67177_CR10","doi-asserted-by":"publisher","first-page":"18964","DOI":"10.1038\/s41598-021-98640-2","volume":"11","author":"K Borkowski","year":"2021","unstructured":"Borkowski, K. et al. Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. Sci. Rep. 11(1), 18964 (2021).","journal-title":"Sci. Rep."},{"issue":"10","key":"67177_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/gerona\/glt177","volume":"69","author":"Z Tucsek","year":"2013","unstructured":"Tucsek, Z. et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-amyloid generation and Alzheimer\u2019s disease. J. Gerontol. Series A. 69(10), 1212\u20131226 (2013).","journal-title":"J. Gerontol. Series A."},{"issue":"42","key":"67177_CR12","doi-asserted-by":"publisher","first-page":"67808","DOI":"10.18632\/oncotarget.12179","volume":"7","author":"P Th\u00e9riault","year":"2016","unstructured":"Th\u00e9riault, P., ElAli, A. & Rivest, S. High fat diet exacerbates Alzheimer\u2019s disease-related pathology in APPswe\/PS1 mice. Oncotarget. 7(42), 67808\u201367827 (2016).","journal-title":"Oncotarget."},{"key":"67177_CR13","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3389\/fimmu.2021.796867","volume":"12","author":"J Xie","year":"2022","unstructured":"Xie, J., Van Hoecke, L. & Vandenbroucke, R. E. The impact of systemic inflammation on Alzheimer\u2019s disease pathology. Front. Immunol. 12, 5731 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"67177_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbr.2012.01.010","volume":"229","author":"MS Kahn","year":"2012","unstructured":"Kahn, M. S. et al. Prolonged elevation in hippocampal A\u03b2 and cognitive deficits following repeated endotoxin exposure in the mouse. Behav. Brain Res. 229(1), 176\u2013184 (2012).","journal-title":"Behav. Brain Res."},{"key":"67177_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-5-37","volume":"5","author":"JW Lee","year":"2008","unstructured":"Lee, J. W. et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflam. 5, 1\u201314 (2008).","journal-title":"J. Neuroinflam."},{"issue":"17","key":"67177_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018101064","volume":"38","author":"D Tejera","year":"2019","unstructured":"Tejera, D. et al. Systemic inflammation impairs microglial A\u03b2 clearance through NLRP 3 inflammasome. EMBO J. 38(17), e101064 (2019).","journal-title":"EMBO J."},{"issue":"3","key":"67177_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","volume":"172","author":"MS Thion","year":"2018","unstructured":"Thion, M. S. et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell. 172(3), 500\u201316.e16 (2018).","journal-title":"Cell."},{"key":"67177_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fnagi.2019.00299","volume":"11","author":"V Murtaj","year":"2019","unstructured":"Murtaj, V. et al. Age and sex influence the neuro-inflammatory response to a peripheral acute LPS challenge. Front. Aging Neurosci. 11, 299 (2019).","journal-title":"Front. Aging Neurosci."},{"issue":"7701","key":"67177_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"A-C Wendeln","year":"2018","unstructured":"Wendeln, A.-C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 556(7701), 332\u2013338 (2018).","journal-title":"Nature."},{"issue":"3","key":"67177_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay, T. R. et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 37(3), 637\u2013647 (2017).","journal-title":"J. Neurosci."},{"issue":"10","key":"67177_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16(10), 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"67177_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","volume":"7","author":"JR Clarke","year":"2015","unstructured":"Clarke, J. R. et al. Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol. Med. 7(2), 190\u2013210 (2015).","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"67177_CR23","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/alz.12714","volume":"19","author":"R Batra","year":"2023","unstructured":"Batra, R. et al. The landscape of metabolic brain alterations in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 19(3), 980\u2013998 (2023).","journal-title":"Alzheimer\u2019s Dementia."},{"key":"67177_CR24","unstructured":"Arnold MA-O, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, et al. Sex and APOE \u03b54 genotype modify the Alzheimer\u2019s disease serum metabolome. (2041\u20131723 (Electronic))."},{"issue":"10","key":"67177_CR25","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.2337\/dc22-0331","volume":"45","author":"G Llaurad\u00f3","year":"2022","unstructured":"Llaurad\u00f3, G. et al. Measurement of serum N-glycans in the assessment of early vascular aging (arterial stiffness) in adults with type 1 diabetes. Diabetes Care. 45(10), 2430\u20132438 (2022).","journal-title":"Diabetes Care."},{"issue":"4","key":"67177_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024380","volume":"11","author":"ST Chiesa","year":"2022","unstructured":"Chiesa, S. T. et al. Glycoprotein acetyls: A novel inflammatory biomarker of early cardiovascular risk in the young. J. Am. Heart Assoc. 11(4), e024380 (2022).","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"67177_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.118.002234","volume":"11","author":"J Kettunen","year":"2018","unstructured":"Kettunen, J. et al. Biomarker glycoprotein acetyls is associated with the risk of a wide spectrum of incident diseases and stratifies mortality risk in angiography patients. Circulat. Genom. Precision Med. 11(11), e002234 (2018).","journal-title":"Circulat. Genom. Precision Med."},{"key":"67177_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2020.100120","volume":"4","author":"NN Mehta","year":"2020","unstructured":"Mehta, N. N., Dey, A. K., Maddineni, R., Kraus, W. E. & Huffman, K. M. GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases. Am. J. Prev. Cardiol. 4, 100120 (2020).","journal-title":"Am. J. Prev. Cardiol."},{"issue":"1","key":"67177_CR29","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1038\/s41467-019-11311-9","volume":"10","author":"J Deelen","year":"2019","unstructured":"Deelen, J. et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat. Commun. 10(1), 3346 (2019).","journal-title":"Nat. Commun."},{"issue":"5","key":"67177_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","volume":"61","author":"JD Otvos","year":"2015","unstructured":"Otvos, J. D. et al. GlycA: A composite nuclear magnetic resonance biomarker of systemic inflammation. Clin. Chem. 61(5), 714\u2013723 (2015).","journal-title":"Clin. Chem."},{"issue":"1","key":"67177_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-015-0646-x","volume":"17","author":"MJ Ormseth","year":"2015","unstructured":"Ormseth, M. J. et al. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Res. Therapy. 17(1), 117 (2015).","journal-title":"Arthritis Res. Therapy."},{"issue":"1","key":"67177_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13075-016-0982-5","volume":"18","author":"DB Bartlett","year":"2016","unstructured":"Bartlett, D. B. et al. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls. Arthritis Res. Therapy. 18(1), 86 (2016).","journal-title":"Arthritis Res. Therapy."},{"key":"67177_CR33","doi-asserted-by":"crossref","unstructured":"Dierckx T, Chiche L, Daniel L, Lauwerys B, Weyenbergh JV, Jourde-Chiche N. Serum GlycA level is elevated in active systemic lupus erythematosus and correlates to disease activity and lupus nephritis severity. J. Clin. Med. 9(4) (2020).","DOI":"10.3390\/jcm9040970"},{"issue":"3","key":"67177_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0961203315617842","volume":"25","author":"CP Chung","year":"2015","unstructured":"Chung, C. P. et al. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus. Lupus. 25(3), 296\u2013300 (2015).","journal-title":"Lupus."},{"issue":"11","key":"67177_CR35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.116.309637","volume":"119","author":"AA Joshi","year":"2016","unstructured":"Joshi, A. A. et al. GlycA Is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis. Circ. Res. 119(11), 1242\u20131253 (2016).","journal-title":"Circ. Res."},{"issue":"8","key":"67177_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/eci.12481","volume":"45","author":"EG Gruppen","year":"2015","unstructured":"Gruppen, E. G., Connelly, M. A., Otvos, J. D., Bakker, S. J. & Dullaart, R. P. A novel protein glycan biomarker and LCAT activity in metabolic syndrome. Eur. J. Clin. Invest. 45(8), 850\u2013859 (2015).","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"67177_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacl.2015.11.009","volume":"10","author":"EG Gruppen","year":"2016","unstructured":"Gruppen, E. G., Connelly, M. A. & Dullaart, R. P. Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects. J. Clin. Lipidol. 10(3), 512\u2013518 (2016).","journal-title":"J. Clin. Lipidol."},{"issue":"6","key":"67177_CR38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/ATVBAHA.115.305635","volume":"35","author":"AO Akinkuolie","year":"2015","unstructured":"Akinkuolie, A. O., Pradhan, A. D., Buring, J. E., Ridker, P. M. & Mora, S. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arteriosclerosis Thrombosis Vasc. Biol. 35(6), 1544\u20131550 (2015).","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"issue":"3","key":"67177_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjy162","volume":"13","author":"T Dierckx","year":"2019","unstructured":"Dierckx, T., Verstockt, B., Vermeire, S. & van Weyenbergh, J. GlycA, a nuclear magnetic resonance spectroscopy measure for protein glycosylation, is a viable biomarker for disease activity in IBD. J. Crohn\u2019s Colitis. 13(3), 389\u2013394 (2019).","journal-title":"J. Crohn\u2019s Colitis."},{"key":"67177_CR40","unstructured":"Dowd JB, Zajacova A Fau - Aiello AE, Aiello AE. Predictors of inflammation in U.S. children aged 3\u201316 years. (1873\u20132607 (Electronic))."},{"key":"67177_CR41","doi-asserted-by":"crossref","unstructured":"Calice-Silva V, Suemoto CK, Brunoni AR, Bensenor IM, Lotufo PA. Association between GlycA and cognitive function: Cross-sectional results from the ELSA\u2014Brasil study. Alzheimer Disease Associated Disorders. 35(2) (2021).","DOI":"10.1097\/WAD.0000000000000431"},{"key":"67177_CR42","unstructured":"Tynkkynen J, Chouraki V, van der Lee SJ, Hernesniemi J, Yang Q, Li S, et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: A prospective study in eight cohorts. (1552\u20135279 (Electronic))."},{"issue":"9","key":"67177_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138036","volume":"10","author":"I Cohen-Manheim","year":"2015","unstructured":"Cohen-Manheim, I. et al. Increase in the inflammatory marker GlycA over 13 years in young adults is associated with poorer cognitive function in midlife. PLoS One. 10(9), e0138036 (2015).","journal-title":"PLoS One."},{"issue":"1","key":"67177_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen, P., Kangas, A. J., W\u00fcrtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. 8(1), 192\u2013206 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"9","key":"67177_CR45","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1039\/b910205a","volume":"134","author":"P Soininen","year":"2009","unstructured":"Soininen, P. et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 134(9), 1781\u20131785 (2009).","journal-title":"Analyst."},{"issue":"9","key":"67177_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz, P. et al. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: A primer on -omic technologies. Am. J. Epidemiol. 186(9), 1084\u20131096 (2017).","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"67177_CR47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer\u2019s disease: A biochemical road map. Alzheimers Dement. 13(9), 965\u2013984 (2017).","journal-title":"Alzheimers Dement."},{"issue":"9","key":"67177_CR48","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu, W. T. et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 79(9), 897\u2013905 (2012).","journal-title":"Neurology."},{"issue":"6","key":"67177_CR49","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","volume":"119","author":"WT Hu","year":"2010","unstructured":"Hu, W. T. et al. Novel CSF biomarkers for Alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol. 119(6), 669\u2013678 (2010).","journal-title":"Acta Neuropathol."},{"key":"67177_CR50","unstructured":"Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, et al. Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: Relationship to neuroimaging and CSF biomarkers. (1552\u20135279 (Electronic))."},{"issue":"4","key":"67177_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","volume":"6","author":"LE Gibbons","year":"2012","unstructured":"Gibbons, L. E. et al. A composite score for executive functioning, validated in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 6(4), 517\u2013527 (2012).","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"67177_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane, P. K. et al. Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 6(4), 502\u2013516 (2012).","journal-title":"Brain Imaging Behav."},{"issue":"5","key":"67177_CR53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner, T. et al. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimer\u2019s Dementia. 12(5), 517\u2013526 (2016).","journal-title":"Alzheimer\u2019s Dementia."},{"key":"67177_CR54","doi-asserted-by":"crossref","unstructured":"Shaw LM, Fields L, Korecka M, Walig\u00f3rska T, Trojanowski JQ, Allegranza D, et al. P2\u2013143: Method Comparison of AB(1\u201342) Measured in Human Cerebrospinal Fluid Samples by Liquid Chromatography-Tandem Mass Spectrometry, the Inno-Bia ALZBIO3 Assay, and the Elecsys\u00ae B-Amyloid(1\u201342) Assay. Alzheimer\u2019s & Dementia. 2016;12(7S_Part_13):P668-P.","DOI":"10.1016\/j.jalz.2016.06.1513"},{"key":"67177_CR55","unstructured":"Mofrad SA, Lundervold AJ, Vik A, Lundervold AS. Cognitive and MRI trajectories for prediction of Alzheimer\u2019s disease. (2045\u20132322 (Electronic))."},{"issue":"2","key":"67177_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1534\/genetics.104.036699","volume":"171","author":"Y Benjamini","year":"2005","unstructured":"Benjamini, Y. & Yekutieli, D. Quantitative trait loci analysis using the false discovery rate. Genetics. 171(2), 783\u2013790 (2005).","journal-title":"Genetics."},{"issue":"1","key":"67177_CR57","doi-asserted-by":"publisher","first-page":"13752","DOI":"10.1038\/s41598-023-39737-8","volume":"13","author":"K Borkowski","year":"2023","unstructured":"Borkowski, K. et al. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. Sci. Rep. 13(1), 13752 (2023).","journal-title":"Sci. Rep."},{"issue":"11","key":"67177_CR58","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1002\/hbm.25455","volume":"42","author":"E Iannopollo","year":"2021","unstructured":"Iannopollo, E. & Garcia, K. Enhanced detection of cortical atrophy in Alzheimer\u2019s disease using structural MRI with anatomically constrained longitudinal registration. Human Brain Mapping. 42(11), 3576\u20133592 (2021).","journal-title":"Human Brain Mapping."},{"key":"67177_CR59","unstructured":"Apostolova LG. Alzheimer Disease. (1538\u20136899 (Electronic))."},{"key":"67177_CR60","doi-asserted-by":"publisher","unstructured":"Olajide OA-O, Suvanto ME, Chapman CA-O. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer\u2019s disease. LID-https:\/\/doi.org\/10.1242\/bio.056796 LID-bio056796. (2046\u20136390 (Electronic)).","DOI":"10.1242\/bio.056796"},{"key":"67177_CR61","unstructured":"Igarashi KM. Entorhinal cortex dysfunction in Alzheimer\u2019s disease. (1878\u2013108X (Electronic))."},{"key":"67177_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.903455","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Koyama, Y. & Shimada, S. Inflammation from peripheral organs to the brain: How does systemic inflammation cause neuroinflammation?. Front. Aging Neurosci. 14, 903455 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"67177_CR63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2362.2002.00994.x","volume":"32","author":"M Fiala","year":"2002","unstructured":"Fiala, M. et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer\u2019s disease brain and damage the blood\u2013brain barrier. Eur. J. Clin. Investig. 32(5), 360\u2013371 (2002).","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"67177_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","volume":"124","author":"T Togo","year":"2002","unstructured":"Togo, T. et al. Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases. J. Neuroimmunol. 124(1), 83\u201392 (2002).","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"67177_CR65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/NMM:7:3:255","volume":"7","author":"T Town","year":"2005","unstructured":"Town, T., Tan, J., Flavell, R. A. & Mullan, M. T-cells in alzheimer\u2019s disease. NeuroMol. Med. 7(3), 255\u2013264 (2005).","journal-title":"NeuroMol. Med."},{"issue":"1","key":"67177_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos, D. A., Olschowka, J. A. & O\u2019Banion, M. K. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J. Neuroinflam. 16(1), 1\u201313 (2019).","journal-title":"J. Neuroinflam."},{"issue":"5","key":"67177_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010830","volume":"5","author":"Y Fisher","year":"2010","unstructured":"Fisher, Y., Nemirovsky, A., Baron, R. & Monsonego, A. T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer\u2019s disease. PloS One. 5(5), e10830 (2010).","journal-title":"PloS One."},{"key":"67177_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00002512-200320020-00002","volume":"20","author":"I Blasko","year":"2003","unstructured":"Blasko, I. & Grubeck-Loebenstein, B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer\u2019s disease. Drugs Aging. 20, 101\u2013113 (2003).","journal-title":"Drugs Aging."},{"key":"67177_CR69","unstructured":"Mendoza C, Zamarripa CAJ. Menopause induces oxidative stress. Morales-Gonz\u00e1lez JA Oxidative stress and chronic degenerative diseases: A role for antioxidants London: Intech Open. 2013:289\u2013316."},{"key":"67177_CR70","unstructured":"Kumar S, Lata K Fau - Mukhopadhyay S, Mukhopadhyay S Fau - Mukherjee TK, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. (0006\u20133002 (Print))."},{"key":"67177_CR71","unstructured":"Tenkorang MA, Snyder B, Cunningham RL. Sex-related differences in oxidative stress and neurodegeneration. (1878\u20135867 (Electronic))."},{"issue":"1","key":"67177_CR72","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"M-V Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier, M.-V. et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun. Biol. 4(1), 711 (2021).","journal-title":"Commun. Biol."},{"issue":"1","key":"67177_CR73","first-page":"13","volume":"7","author":"N Yanguas-Cas\u00e1s","year":"2020","unstructured":"Yanguas-Cas\u00e1s, N. Physiological sex differences in microglia and their relevance in neurological disorders. Neuroimmunol. Neuroinflam. 7(1), 13\u201322 (2020).","journal-title":"Neuroimmunol. Neuroinflam."},{"issue":"1","key":"67177_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12974-017-0920-8","volume":"14","author":"CA Mangold","year":"2017","unstructured":"Mangold, C. A. et al. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J. Neuroinflam. 14(1), 141 (2017).","journal-title":"J. Neuroinflam."},{"issue":"2","key":"67177_CR75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-019-0560-7","volume":"23","author":"L Kodama","year":"2020","unstructured":"Kodama, L. et al. Microglial microRNAs mediate sex-specific responses to tau pathology. Nat. Neurosci. 23(2), 167\u2013171 (2020).","journal-title":"Nat. Neurosci."},{"issue":"7784","key":"67177_CR76","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature. 575(7784), 669\u2013673 (2019).","journal-title":"Nature."},{"issue":"1","key":"67177_CR77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju, S. et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol. Neurodegenerat. 13(1), 24 (2018).","journal-title":"Mol. Neurodegenerat."},{"issue":"1","key":"67177_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","volume":"22","author":"M Divangahi","year":"2021","unstructured":"Divangahi, M. et al. Trained immunity, tolerance, priming and differentiation: Distinct immunological processes. Nat. Immunol. 22(1), 2\u20136 (2021).","journal-title":"Nat. Immunol."},{"issue":"3","key":"67177_CR79","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan, A. M. et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans. Ann. Neurol. 59(3), 512\u2013519 (2006).","journal-title":"Ann. Neurol."},{"issue":"1","key":"67177_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-021-01253-z","volume":"9","author":"J Xie","year":"2021","unstructured":"Xie, J. et al. Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 9(1), 163 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"67177_CR81","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang S, Li X, Liu E, Wang X, Zhou Q, et al. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier. Biosci. Rep. 40(2) (2020).","DOI":"10.1042\/BSR20193629"},{"issue":"6","key":"67177_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1212\/WNL.0000000000002950","volume":"87","author":"W Li","year":"2016","unstructured":"Li, W., Risacher, S. L., Huang, E. & Saykin, A. J. Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology. 87(6), 595\u2013600 (2016).","journal-title":"Neurology."},{"issue":"12","key":"67177_CR83","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jagp.2014.02.007","volume":"22","author":"NJ Donovan","year":"2014","unstructured":"Donovan, N. J. et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am. J. Geriatr. Psychiatry. 22(12), 1642\u20131651 (2014).","journal-title":"Am. J. Geriatr. Psychiatry."},{"issue":"4","key":"67177_CR84","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"F Jessen","year":"2010","unstructured":"Jessen, F. et al. Prediction of dementia by subjective memory impairment: Effects of severity and temporal association with cognitive impairment. Arch. General Psychiatry. 67(4), 414\u2013422 (2010).","journal-title":"Arch. General Psychiatry."},{"issue":"1","key":"67177_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12072","volume":"6","author":"S-E Choi","year":"2020","unstructured":"Choi, S.-E. et al. Development and validation of language and visuospatial composite scores in ADNI. Alzheimer\u2019s Dementia Transl. Res. Clin. Interventions. 6(1), e12072 (2020).","journal-title":"Alzheimer\u2019s Dementia Transl. Res. Clin. Interventions."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67177-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T10:15:46Z","timestamp":1722248146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67177"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67177-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.08.23299734","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Rima Kaddurah-Daouk and Dr. Matthias Arnold participated in the invention of several patents on applying metabolomics to diagnose and treat CNS diseases. Dr. Kaddurah-Daouk holds equity in Metabolon Inc., Chymia LLC and PsyProtix, which were not involved in the current study. Dr. Arnold holds equity in Chymia LLC and IP in PsyProtix. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17423"}}